Completed
The Institute of Medicine report, Lost in Transition, made recommendations to improve the quality of care for cancer survivors – a population at risk for an array of significant physical, psychosocial, and financial effects of cancer and cancer treatment. Since then, coordinated efforts to address the unique needs of cancer survivors have increased, including work to improve the evidence base for cancer survivorship care and to identify best practices in the delivery of high-quality cancer survivorship care. This workshop examined progress from 2006 to 2017 and considered potential actions to improve the planning, management, and delivery of cancer survivorship care.
Featured publication
Workshop
·2018
The 2006 Institute of Medicine (IOM) consensus study report From Cancer Patient to Cancer Survivor: Lost in Transition made recommendations to improve the quality of care that cancer survivors receive, in recognition that cancer survivors are at risk for significant physical, psychosocial, and finan...
View details
Description
An ad hoc committee will plan and host a 1.5-day public workshop to examine the evidence for potential actions to improve the planning, management, and delivery of cancer survivorship care. The workshop will feature invited presentations and panel discussions on topics that may include:
• An overview of the health risks and late effects experienced by cancer survivors.
• The current evidence base to improve the quality of life for cancer survivors, including the identification, prevention, and reduction of long-term toxicities and second malignancies associated with prior cancer treatment.
• Strategies for early integration of psychosocial support in survivorship care.
• Opportunities to overcome challenges in accessing health care and minimizing the financial burden for cancer survivors.
• Implementation models and emerging strategies for coordinated cancer survivorship care in primary and specialty care settings, including the use of survivorship care plans tailored to a patient’s diagnosis and life course.
• Changes in the landscape of cancer survivorship care over the past decade.
The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Sponsors
Abbott Laboratories
American Association for Cancer Research
American College of Radiology
American Society of Clinical Oncology
American Society of Hematology
Association of American Cancer Institutes
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Helsinn Therapeutics (U.S.), Inc.
LiveSTRONG Foundation
Merck
National Cancer Institute
National Comprehensive Cancer Network
National Institutes of Health
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Staff
Sharyl Nass
Lead
Erin Balogh
Lead
Laura Aiuppa
Lead
Cyndi Trang